Angela M Cacace sold $55k of ARVN
Chief Scientific Officer at ARVINAS, INC.. 4,592 shares at an average of $11.89, traded Feb 13, 2026, filed Feb 18, 2026.
Score components
- +15RoleOfficer
- +7Trade size$55k at market
- 0Share of holdings soldSold 2.9% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-009303, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | SOpen-market sale Common Stock | -4,592 | $11.89 | $55k | 151,232 | Feb 18, 2026 |
Related signals
Other insiders at ARVINAS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | ARVNsell ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $71k 6,435 shares | -3% | |
| 38Weak | ARVNbuy ARVINAS, INC. | Briggs Morrison director | $268k 20,000 shares | +26% | |
| 47Moderate | ARVINAS, INC. | John G Houston President and CEO | $466k 35,297 shares | -3% | |
| 47Moderate | ARVINAS, INC. | Randy Teel President and CEO | $58k 4,786 shares | -3% | |
| 36Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $44k 3,609 shares | -2% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $13k 1,108 shares | -4% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $12k 1,016 shares | -3% | |
| 38Weak | ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $68k 5,685 shares | -3% | |
| 44Moderate | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $61k 5,134 shares | -3% | |
| 47Moderate | ARVINAS, INC. | Randy Teel President and CEO | $52k 4,403 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.